SCHEMBL4080372

SCHEMBL4080372

O=C(O)NC(c1cccs1)c1cccs1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.46
CES1 P23141 2/20 0.46
KEAP1 Q14145 1/20 0.46
ALOX5 P09917 1/20 0.42
DAO P14920 1/20 0.42
GAA P10253 2/20 0.40
CYP2C19 P33261 2/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HDAC1 Q13547 1/20 0.39
TSHR P16473 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
GFER P55789 1/20 0.39
POLB P06746 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1585852 0.82 TSHR (0.43) CES2CES1KEAP1GAACYP2C19
SCHEMBL10452109 0.81 CES2 (0.43) CES2CES1KEAP1ALOX5DAO
SCHEMBL27826689 0.81 ALDH1A1 (0.52) CES2CES1KEAP1ALOX5GAA
SCHEMBL10452064 0.77 CES2 (0.40) CES2CES1KEAP1ALOX5DAO
SCHEMBL7685599 0.77 ALOX5 (0.41) CES2CES1KEAP1ALOX5GAA
SCHEMBL4084228 0.73 MAPT (0.44) GAACYP2C19ALDH1A1MEN1KMT2A
SCHEMBL2305731 0.72 CES2 (0.50) CES2CES1KEAP1ALOX5DAO
SCHEMBL72374 0.72 CES2 (0.50) CES2CES1KEAP1ALOX5DAO
Fluoride SCHEMBL14774852 0.71 CES2 (0.48) CES2CES1KEAP1ALOX5DAO
SCHEMBL12238427 0.71 CES2 (0.63) CES2CES1KEAP1ALOX5DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054480-A1 NOVEL QUINUCLIDINE CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME LABORATORIOS ALMIRALL S.A. 2009-02-26 US disclosed
US-20090005412-A1 NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME LABORATORIOS ALMIRALL S.A. 2009-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005412-A1 NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME CHRM3, CHRM2, CHRM1 CES2 529/4885CES1 952/4885KEAP1 3022/4885
US-20090054480-A1 NOVEL QUINUCLIDINE CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME CHRM3, CHRM2, CHRM1 CES2 555/4885CES1 798/4885KEAP1 3434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.